Prab: CSV import

2025-03-17T16:49:47Z

CSV import

← Older revision		Revision as of 16:49, 17 March 2025
Line 31:		Line 31:
	{{Medicine-stub}}		{{Medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T03:03:39Z

CSV import

← Older revision		Revision as of 03:03, 11 February 2025
Line 30:		Line 30:

	{{Medicine-stub}}		{{Medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-19T07:11:02Z

CSV import

New page

'''Leucine-rich repeat kinase 2''' ('''LRRK2'''), also known as '''dardarin''', from the Basque word "dardara" which means tremor, is a protein that in humans is encoded by the ''LRRK2'' gene. LRRK2 is a multifunctional protein kinase involved in a variety of cellular processes including [[neurogenesis]], [[neuronal plasticity]], and [[autophagy]]. It has garnered significant attention due to its association with [[Parkinson's disease]], making it a focal point of neurodegenerative research.

== Function ==
LRRK2 is a large and complex enzyme that belongs to the ROCO protein family, characterized by the presence of a Ras of complex proteins (ROC) domain. It possesses multiple domains including a kinase domain, a GTPase domain, and several protein-protein interaction domains such as the leucine-rich repeat (LRR) and WD40 domains. This unique structure allows LRRK2 to participate in various cellular functions, acting as both a kinase and a GTPase. Its activity is implicated in the regulation of [[neuron]]al morphology, [[vesicle trafficking]], [[mitochondrial function]], and [[cytoskeletal dynamics]].

== Pathology ==
Mutations in the ''LRRK2'' gene are the most common genetic cause of Parkinson's disease, accounting for a significant percentage of both familial and sporadic cases. The most well-known mutation, Gly2019Ser, increases the kinase activity of LRRK2, leading to neurodegeneration. The exact mechanisms by which LRRK2 mutations cause [[neurodegeneration]] are not fully understood, but they are believed to involve aberrant phosphorylation of substrates, impaired mitochondrial function, and dysregulated autophagy.

== Clinical Significance ==
The discovery of LRRK2's role in Parkinson's disease has made it a promising target for therapeutic intervention. Inhibitors of LRRK2 kinase activity are currently being explored as potential treatments for Parkinson's disease, with the aim of preventing, slowing, or stopping disease progression. Additionally, LRRK2 is being investigated in the context of other neurodegenerative diseases, suggesting a broader relevance of this kinase in neurodegeneration.

== Research Directions ==
Research on LRRK2 continues to evolve, with studies focusing on understanding its normal physiological functions, the pathogenic effects of mutations, and the development of specific inhibitors that can modulate its activity without causing adverse effects. The elucidation of LRRK2's structure has been a significant milestone, providing insights into its enzymatic mechanisms and facilitating the design of targeted therapies.

== See Also ==
* [[Parkinson's disease]]
* [[Protein kinase]]
* [[Neurodegeneration]]
* [[Autophagy]]

== References ==
<references/>

== External Links ==
* [https://www.parkinsons.org.uk/information-and-support/what-lrrk2 Parkinson's UK: What is LRRK2?]

[[Category:Protein kinases]]
[[Category:Genes on human chromosome 12]]
[[Category:Parkinson's disease]]

{{Medicine-stub}}

LRRK2 - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import